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Summary
Objective: To provide a more complete picture of the effect of interleukin-1 beta (IL-1b) on adult human articular chondrocyte gene expression,
in contrast to the candidate gene approach.
Design: Chondrocytes from human knee cartilage were cultured in medium containing IL-1b. Changes in gene expression were analyzed by
microarray and reverse transcriptase-polymerase chain reaction analysis. The ability of transforming growth factor beta-1 (TGF-b1), ﬁbroblast
growth factor (FGF)-18, and bone morphogenetic protein 2 (BMP-2) to alter the effects of IL-1b was analyzed. Computational analysis of the
promoter regions of differentially expressed genes for transcription factor binding motifs was performed.
Results: IL-1b-treated human chondrocytes showed signiﬁcant increases in the expression of granulocyte colony stimulating factor-3, endo-
thelial leukocyte adhesion molecule 1 and leukemia inhibitory factor as well as for a large group of chemokines that include CXCL1, CXCL2,
CXCL3, CXCL5, CXCL6, CXCL8, CCL2, CCL3, CCL4, CCL5, CCL8, CCL20, CCL3L1, CX3CL1 and the cytokine IL-6. As expected, the
mRNA for matrix metalloproteinase (MMP)-13 and BMP-2 also increased while mRNA for the matrix genes COL2A1 and aggrecan was
down-regulated. A subset of chemokines increased rapidly at very low levels of IL-1b. The phenotype induced by IL-1b was partially reversed
by TGF-b1, but not by BMP-2. In the presence of IL-1b, FGF-18 increased expression of ADAMTS-4, aggrecan, BMP-2, COL2A1, CCL3,
CCL4, CCL20, CXCL1, CXCL3, CXCL6, IL-1b, IL-6, and IL-8 and decreased ADAMTS-5, MMP-13, CCL2, and CCL8. Computational analysis
revealed a high likelihood that the most up-regulated chemokines are regulated by the transcription factors myocyte enhancer binding factor-3
(MEF-3), CCAAT/enhancer binding protein (C/EBP) and nuclear factor-kappa B (NF-kB).
Conclusion: IL-1b has a diverse effect on gene expression proﬁle in human chondrocytes affecting matrix genes as well as chemokines and
cytokines. TGF-b1 has the ability to antagonize some of the phenotype induced by IL-1b.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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IL-1b is an important cytokine in rheumatoid and osteoar-
thritic (OA) joint diseases. Generally, IL-1b is viewed as
a catabolic factor for cartilage, inducing enzymes that
degrade the extracellular matrix (ECM)1,2 and reducing syn-
thesis of the primary cartilage components type II collagen
(COL2A1) and aggrecan3. On the other hand, it has
recently been shown that IL-1b can also induce the growth
and morphogenetic factor BMP-24 potentially helping to
balance its catabolic effects. In joint diseases, IL-1b isaCurrent address: Department of Medicine, Division of Oncology,
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1560synthesized by synovial cells5 and cartilage chondrocytes6,
therefore, its effect on chondrocytes is highly relevant to the
fate of cartilage. In order to obtain a global picture of IL-1b
effects on human adult articular chondrocytes, we analyzed
the changes in gene expression induced by IL-1b by gene
expression array analysis. A dramatic response was ob-
served in a speciﬁc set of chemokine genes.
Chemokines are potent mediators of inﬂammation and
are known to be important in inﬂammatory diseases such
as rheumatoid arthritis, inﬂammatory bowel disease, multi-
ple sclerosis and transplant rejection7. Certain chemokines
mediate inﬁltration of leukocytes in synovial tissue and
ﬂuid8. Initially discovered as co-receptors for HIV entry
into lymphocytes, they are now known to be involved in
chemoattraction, cell adhesion and migration. Extracellular
gradients of chemokines are established by binding to
glycosaminoglycan chains in the ECM9 and at the cell
surface chemokines can modulate integrin integrity10.
The chemokine CXCL12/stromal cell-derived factor-1
(SDF-1) increases MMP-3 activity11.
1561Osteoarthritis and Cartilage Vol. 16, No. 12There exist over 50 chemokine ligands and 18 chemo-
kine receptors12. The largest families of chemokines have
similar protein structure being 8e10 kDa with conserved
cysteine residues either adjacent (CC) or separated by
one amino acid (CXC)13. Very little is known about their reg-
ulation at the gene transcription or protein levels, however,
speciﬁc chemokines have been shown to be up-regulated
by NF-kB and factors that enhance NF-kB14. As IL-1b stim-
ulates anabolic as well as catabolic events, we determined
whether treatment with anabolic agents ﬁbroblast growth
factor (FGF)-18, BMP-2 or TGF-b1 could alter aspects of
the IL-1b-induced chemokine phenotype.
MethodsMATERIALSPRONASE, Streptomyces griseus Protease, was from CALBIOCHEM (La
Jolla, CA). Collagenase P was from Roche (Indianapolis, IN). Recombinant
human IL-1b, TGF-b1 and BMP-2 were from R&D Systems (Minneapolis,
MN). Recombinant human FGF-18 was from Leinco Technologies (St. Louis,
MO). TRIZOL reagent, ampliﬁcation grade DNase I, SuperScript II Reverse
Transcriptase and Platinum Taq DNA Polymerase were from Invitrogen
(Carlsbad, CA). RNeasy Mini kit was from Qiagen (Valencia, CA).CELL AND TISSUE CULTURECartilage was obtained with approval of the Washington University
Human Studies Review Board and permission of the patient. Normal chon-
drocytes were obtained from normal articular knee cartilage from tissue
donors (N¼ 4) with above the knee amputations due to chondrosarcoma
or traumatic injury or from autopsy. Chondrocytes were also obtained from
OA cartilage from donors (N¼ 11) undergoing total joint replacement
surgery. For the latter, chondrocytes from macroscopically normal looking
cartilage were used; patients were of both sexes and greater than 60 years
of age. Chondrocytes were isolated following previously published proce-
dures4 and plated at a density of 2.5 105 cells/cm2 in Dulbecco’s modiﬁed
eagle’s medium (DMEM)/F12 media plus 10% fetal bovine serum (FBS),
50 mg/ml ascorbate and antibiotics (50 U/ml penicillin and 50 mg/ml strepto-
mycin). Cells were allowed to recover for 24 h and cytokines or growth fac-
tors (IL-1b/TGF-b1/FGF-18/BMP-2) were added at the concentrations and
times indicated. To study the response of cartilage explants to IL-1b, ex-
plants from a total joint replacement surgery were used. Cartilage was cul-
tured with and without IL-1b prior to isolation of RNA directly from the
tissue. IL-1b was reconstituted in sterile phosphate-buffered saline (PBS)
containing 0.1% bovine serum albumin; FGF-18 was reconstituted in 5 mM
Tris, pH 8.0; BMP-2 and TGF-b1 were reconstituted in 4 mM HCl containing
0.1% bovine serum albumin. The time course, concentration gradient andTable
Primers for PCR
IL-6 F (50-GCCACTCAC
CXCL8 (IL-8) F (50-GACTTCCAA
NOS2B F (50-GAGTGCAG
NFKBIA F (50-GCTGAAGAA
CCL2 (MCP-1) F (50-GCATGAAAG
CCL3 (MIP-1a) F (50-GCTGCCCTT
CCL4 (MIP-1b) F (50-GCGCTCTCA
CCL5 (RANTES) F (50-GAAGGTCTC
CCL8 (MCP-2) F (50-GCCTGCTG
CCL20 (MIP-3a) F (50-GCTGTACCA
CCL3L1 (LD78b) F (50-GTCTCCACT
CXCL1 (GRO-a) F (50-GCTCCTGCG
CXCL2 (GRO-b) F (50-CACAGCCG
CXCL3 (GRO-g) F (50-GCAGGAGC
CXCL5 (ENA-78) F (50-GAGCCTCC
CXCL6 (GCP-2) F (50-GCGAACCC
CX3CL1 (fractalkine) F (50-GCTTGGCC
BMP-2 F (50-GGACACGC
ADAMTS-4 F (50-CAGATGTGG
IL-1b; COL2A1; MMP-13; ADAMTS-5;
aggrecan and TNF-a58
GAPDH59effects of TGF-b1, FGF-18 and BMP-2 were repeated on a minimum of three
biological replicates (one normal and two from joint replacement surgery). All
experiments were repeated three times with cells from the same patient.
Each ﬁgure shows data from a single donor. At no point were cells pooled
from different donors. The experiments shown in the ﬁgures are representa-
tive of all of the data.TOTAL RNA ISOLATIONTotal RNA was isolated from primary chondrocytes or cartilage explants
by homogenizing these directly into TRIZOL reagent (Invitrogen) and follow-
ing the protocol recommended by the manufacturer. For microarray analysis,
RNA was further puriﬁed by Qiagen RNeasy Mini kit. For reverse transcrip-
tase-polymerase chain reaction (RT-PCR) analysis the isolated RNA was
treated by DNase I to remove traces of contaminating DNA.MICROARRAY ANALYSISFor microarray analysis, ﬁrst strand cDNA was generated from RNA and
labeled with the Cy3 and Cy5 ﬂuorescent dyes using the 3DNA Array 900 kit
(Genisphere), without any prior ampliﬁcation of the RNA. The hybridization
was performed on the Human Operon V3.0 Oligo Expression Array (White-
head Institute, Cambridge) which consists of 34,580 human 70-mer probes
representing 24,650 genes and 37,123 gene transcripts. The analysis was
repeated with the Cy3 and Cy5 dyes exchanged between the control and ex-
perimental RNAs. The arrays were scanned on a Perkin Elmer ScanArray
ExpressHT scanner to detect Cy3/Cy5 ﬂuorescence. Analysis of images
was performed by ScanArray v.3.0 (Perkin Elmer). To generate a stringent
list of candidates demonstrating differential expression only those candidates
that scored a local signal-to-background differential intensity of 2 in two
biological and two technical replicates (due to reversal of dyes) and had
a P-value of less than 0.05 were considered. The raw microarray data are
accessible from NCBI’s Gene Expression Omnibus (GEO) repository through
GEO Series accession number GSE11427 (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE11427).SEMI-QUANTITATIVE RT-PCR ANALYSISThe RT-PCR was performed using total RNA isolated from primary chon-
drocytes or fresh cartilage tissue by SuperScript II Reverse Transcriptase as
recommended by Invitrogen. Primers used for PCR were optimized for each
gene (Table I). PCR was performed in a total volume of 20 ml by Platinum
Taq DNA Polymerase as recommended by Invitrogen. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as a reference for gel load-
ing. cDNA samples from different time points and treatments for each
gene were simultaneously ampliﬁed in PCR and repeated at least thrice to
avoid potential variation between experiments. Results were analyzed using
NIH IMAGE J software, tested using standards with known concentrations, to
determine the pixel intensity for each concentration. The ampliﬁcation cycle
number used to yield product in the linear range was determined for each set
of primers. A standard curve was established for each set of PCRs.I
analysis
CTCTTCAGAA-30), R (50-GTACTCATCTGCACAGCTCT-30)
GCTGGCCGT-30), R (50-GAATTCTCAGCCCTCTTCA-30)
GGAGGCCGCAT-30), R (50-CTTGGGCTTGCCAGGCAG-30)
GGAGCGGCTA-30), R (50-CTGGCTGGTTGGTGATCA-30)
TCTCTGCCG-30), R (50-GAGTGTTCAAGTCTTCGGA-30)
GCTGTCCTCCTC-30), R (50-GGTCAGCACAGACCTGCCGG-30)
GCACCAATGGGC-30), R (50-GCATCCGGGCTCAGGTGACC-30)
CGCGGCAGCC-30), R (50-CTGGGCCCTTCAAGGAGCGG-30)
CTCATGGCAGCC-30), R (50-GCACAGACCTCCTTGCCCCG-30)
AGAGTTTGCT-30), R (50GGCTATGTCCAATTCCATT-30)
GCTGCCCTTGCC-30), R (50-CTGAGGTCGCTGGGCCTCGA-30)
AGTGGCACTGC-30), R (50-GGGCCTCCTTCAGGAACAGCC-30)
CTCGAACCGCCT-30), R (50-GCGCAAGCCAGGTGGCCTCT-30)
GTCCGTGGTCAC-30), R (50-GCTCTGGTAAGGGCAGGGACC-30)
TGTCCAGCCGC-30), R (50-CACCTTGGAGCACTGTGGGCC-30)
TCTCTTGACCA-30), R (50-CTTGTTTCCACTGTCCAA-30)
ACCTTCTGCCAT-30), R (50-GTCGGCTCCAGGCTACTGCT-30)
CAACCATGGATT-30), R (50-CAACCATGTCCTGATAGTTCT-30)
TACTGCCTGGG-30), R (50-GCCGCCGAAGGATCTCCAGA-30)
1562 L. J. Sandell et al.: Adult chondrocyte response to IL-1bCOMPUTATIONAL ANALYSISPotential regulatory DNA surrounding the chemokine genes was analyzed
by the Promoter Analysis Pipeline15,16. Brieﬂy, the Promoter Analysis Pipe-
line has two components: a set of algorithms to generate the results of a ge-
nome-wide promoter analysis and a user interface to query and process the
stored data according to speciﬁc parameters. Promoters (10 kb upstream
and 5 kb downstream of the transcription start site) were acquired from three
species human, mouse and rat, and repetitive elements in the promoters
were masked. Promoters of orthologous genes were aligned and transcrip-
tion factor binding sites were identiﬁed using the TRANSFAC 7.2 database,
a curated database of transcription factor proﬁles17. Probability scores for
each promoter and each transcription factor were calculated and a distribu-
tion of probability scores was generated for each transcription factor. R-
scores were then computed using these distributions15. This system was
used to predict the transcription factors that are most likely to bind to and
regulate the set of genes. For each transcription factor binding site motif
(identiﬁed by the TRANSFAC accession number) and each promoter in
the genome, the probability score of the transcription factor binding to the
promoter was computed by summing the exponential of the score of each
individual site predicted in the promoter on either strand18. This score is
set to a minimum value of 1 for a promoter with no sites exceeding the cutoff.
The rank of this score is converted to the R-score which is related to the frac-
tion of promoters with a higher rank, by R-score¼ lnN ln(rank). Promoters
ranked in the top half have R-score ln 2, those in the top 10% have R-
score> ln 10, those in the top 1% have R-score> ln 100. The R-score for
a set of n promoters, the average R-score, CR-scoreD, is calculated by CR-
scoreD¼ (1/n)P(R-score).ResultsMICROARRAY ANALYSISChanges in mRNA levels induced by IL-1b were
assessed by microarray analysis (Table II), several of which
were conﬁrmed by PCR analysis of mRNA (Fig. 1 and Table
II). The most highly regulated genes are listed in Table II.
Among the most increased were granulocyte colony stimu-
lating factor (CSF)-3, endothelial leukocyte adhesion mole-
cule 1/E-selectin (SELE) and leukemia inhibitory factor
(LIF), 76-fold, 65-fold and 49-fold, respectively. As a group
of related genes, the chemokines were the most highly up-
regulated: CXCL1, CXCL2, CXCL3, CXCL6, CXCL8, CCL3,
CCL3L1, CCL4 and CCL20. Genes that have been previ-
ously reported to respond to IL-1b and thus can be consid-
ered as controls were regulated as expected: MMP-13 was
up-regulated 6-fold19 and type II collagen (COL2A1) was
down-regulated by 60%3. The nitric oxide synthases, nitric
oxide synthase IIB (NOS2B), and NOS2A (inducible NOS,
type IIA) were increased 23-fold and 20-fold, respectively.
NF-kB inhibitor alpha (NFKBIA) was increased 15-fold.
The cytokines IL-8 (also known as the chemokine
CXCL8), IL-6 and IL-1b were also increased over 20-fold.
Interestingly, the enzyme, ADAMTS-5 (aggrecanase-2)
was present in the cultured chondrocytes at high levels
and reproducibly down-regulated by exposure to IL-1b
(Table II and Figs. 1 and 2). In some cases of veriﬁcation
of the gene array results by PCR, increases in mRNA level
were difﬁcult to quantify as the normal chondrocyte control
used for the gene array contains little chemokine mRNA.
However, the increases are in the order of magnitude
revealed by the gene array data.DOSE RESPONSE OF IL-1b-INDUCED
CHANGES IN PHENOTYPEAs the response to exposure to 10 ng/ml was reproduc-
ibly strong, we determined the effect of physiological
concentrations of IL-1b on the increase in chemokine
mRNA by chondrocytes. Normal chondrocytes (from indi-
viduals with no history of OA) were exposed to IL-1b at
0.01, 0.1 and 1 ng/ml. At even the lowest concentration of
0.01 ng/ml of IL-1b, many of the chemokine mRNAs weredramatically increased [Fig. 2(A)]. The down-regulation of
COL2A1 gene showed a dose response beginning at
0.01 ng/ml. MMP-13 was strongly induced by 0.01 ng/ml
while ADAMTS-4 was weakly induced at 0.01 ng/ml, but
strongly induced by 0.1 ng/ml IL-1b. In summary, the genes
induced by 0.01 ng/ml of IL-1b were ADAMTS-4, MMP-13,
NFKBIA, BMP-2, NOS2B, IL-8, IL-6, CCL2, CCL8, CCL20
and CX3CL1. The quantiﬁcation of these results is shown
in Fig. 2(B). The response of chondrocytes to IL-1b was
found to be very reproducible between donors and experi-
ments. Note that some of the chemokine PCR products
seem to be at maximum levels with 0.1 ng/ml, however,
these were tested at lower rounds of ampliﬁcation and
found to be indeed at maximum levels as shown.TIME COURSE OF IL-1b-INDUCED CHANGES IN PHENOTYPEIn order to begin to ascertain which genes are coordi-
nately regulated by IL-1b, RNA was isolated at 1, 4, 8, 12
and 24 h after treatment. Three patterns of regulation
were observed (Fig. 3). The ﬁrst pattern was molecules
up-regulated by 1 h: TNF-a, NFKBIA, CCL2, CCL3, CCL4,
CCL8, CX3CL1 and CXCL3. Of these genes up-regulated
at 1 h, TNF-a and NFKBIA decreased throughout the
remaining time period. CCL4, CCL3, CCL2 and CXCL3
remained high throughout the time period. At 4 h,
ADAMTS-4, MMP-13, BMP-2, NOS2B, IL-6, CXCL8/IL-8,
IL-1b, CCL3L1, CCL20, CCL5, CXCL5 and CXCL1 were
up-regulated. ADAMTS-4, BMP-2, IL-1b and NOS2B re-
mained up-regulated at 8 and 12 h, but were reduced by
24 h. At 8 h, CXCL6 and CXCL2 appeared and remained
high even at 24 h. The down-regulation of the matrix mole-
cules, COL2A1 and aggrecan, occurred at 24 h. Thus, there
appear to be a number of signal transduction pathways
leading to the phenotypic changes induced by IL-1b. A
consistent observation is that up-regulation of cytokines,
chemokines and degradative enzymes appears to be
more rapid than the down-regulation of matrix gene expres-
sion. In addition to providing insight on the different
pathways of regulation, these results indicate that it is
very important to consider the time point at which effects
of IL-1b are analyzed.REVERSAL OF IL-1b-INDUCED PHENOTYPE
BY BMP-2 AND TGF-b1We tested the potential for these growth and differentiation
factors to reverse the IL-1b-induced increase in chemokine
expression (Fig. 4). In these set of experiments, chondro-
cytes were cultured with IL-1b for 24 h, the medium changed
and the growth factors TGF-b1 andBMP-2were added to cell
cultures for an additional 48 h. 0.1 ng/ml of IL-1bwas used as
it is sufﬁcient to easily see the effects of the cytokine on gene
expression. Chondrocytes from normal cartilage and carti-
lage removed from patients undergoing total joint replace-
ment for OA were used. In cells from both normal cartilage
and OA cartilage, all genes were regulated by IL-1b as
predicted from the gene array results. Interestingly, cells
from OA cartilage without IL-1b treatment demonstrated
changes in gene expression very similar to normal chondro-
cytes exposed to lower concentration (0.1 ng/ml) of IL-1b
(Fig. 4, denoted by *). Many of these genes are also up-
regulated at the lowest concentration (0.01 ng/ml) of IL-1b
[Fig. 2(A)] in normal chondrocytes. This suggests that our in
vitro experiments are duplicating a potential in vivo effect
taking place during OA. Under the reversal conditions used
in this set of experiments, TGF-b1 was able to reduce the
Table II
Microarray and RT-PCR analysis. Gene changes in mRNA levels induced by IL-1b were assessed by microarray analysis, several of which
were confirmed by RT-PCR analysis
Gene transcripts Microarray (relative intensity) RT-PCR (pixel intensity)
Control IL-1b,
10 ng/ml
Fold
change
Control IL-1b,
10 ng/ml
Fold
change
Highest up-regulated (20e76-fold)
Granulocyte CSF-3) 45.99 2530.75 76 ND
SELE (endothelial leukocyte adhesion
molecule 1/E-selectin)
80.88 3683.50 65 ND
LIF (leukemia inhibitory factor) 332.04 16253.50 49 ND
ADORA2A (adenosine A2A receptor) 68.51 1699.00 31 ND
PIM2 (serine threonine protein kinase) 251.93 6564.50 26 ND
PTGS2 (Cox-2) 1042.71 24325.25 23 ND
IL-6 2508.05 65050.50 26 0 8923 Z
NOS2B 491.39 11247.50 23 0 8576 Z
IL-1b 219.19 4123.00 20 0 8232 Z
RAC1 (RAS-like protein TC25) 574.16 12403.50 20 ND
NOS2A (inducible NOS, type II) 324.74 6186.00 20 ND
Chemokine transcripts
Group 1 (25e75-fold)
CXCL2 (GRO-b) 434.41 32632.25 75 ND
CXCL8 (IL-8) 1159.28 65126.50 57 0 8607 Z
CXCL1 (GRO-a) 1648.54 65214.75 40 0 7337 Z
CXCL3 (GRO-g) 485.25 18605.75 40 ND
CCL4 (MIP-1b) 221.41 6616.00 36 ND
CCL20 (MIP-3a) 1902.24 65190.25 35 0 8926 Z
CCL3L1 (LD78b) 346.80 12004.50 34 ND
CXCL6 (GCP-2) 2040.93 56281.75 28 0 8532 Z
CCL3 (MIP-1a) 343.49 8495.75 25 ND
Group 2 (3e12-fold)
CCL5 (RANTES) 149.47 1686.00 12 ND
CXCL5 (ENA-78) 663.20 4155.00 6 ND
CX3CL1 (fractalkine) 237.90 1414.25 6 0 8080 Z
CCL2 (MCP-1) 3151.44 13374.75 4 2345 8996 3.84
CCL8 (MCP-2) 47.77 181.00 3 ND
Other transcripts of interest
NOS2C 825.84 12485.75 15 ND
IL-24 79.43 906.75 15 ND
NFKBIA 1424.45 20898.5 15 0 8834 Z
MMP-13 6784.55 42234.75 6 2097 8232 3.93
COL2A1 11152.09 4873.00 0.44 8524 4341 0.51
ADAMTS-5 1566.57 205.75 0.13 8473 4211 0.50
Aggrecan NDT NDT e 8718 4771 0.55
BMP-2 NDT NDT e 6742 8482 1.26
NDT: not detected. ND: not determined. Z: IL-1b-induced gene change is radically higher than in control group without IL-1b treatment.
1563Osteoarthritis and Cartilage Vol. 16, No. 12up-regulatory effects of IL-1bonCCL2,CCL4,CCL8,CCL20,
and MMP-13 and reversed the down-regulation of COL2A1
(Fig. 5). In some cases such as that seen with CXCL1,
CXCL3, and CCL3L1 the reversal was more pronounced
with chondrocytes from normal patients and in case of
CCL3, CXCL2, and IL-1b the reversal was more
pronounced with chondrocytes from OA patients. BMP-2
somewhat reversed the down-regulation of COL2A1, but
had little effect on chemokine levels (data not shown). Sur-
prisingly, while TGF-b1 was able to reverse much of the IL-
1b-induced phenotype, TGF-b1 also induced a dramatic
increase in ADAMTS-4 in both normal and OA cartilages.FGF-18 EFFECT ON IL-1b-INDUCED PHENOTYPEIn an independent set of experiments, we asked whether
there would be more effect of growth factors when the low-
est concentration of IL-1b was used (0.01 ng/ml). In these
experiments, IL-1b remained in the culture and TGF-b1,BMP-2 and FGF-18 were added after 24 h. Under these
conditions, the BMP-2 and TGF-b1 demonstrated effects
similar to the previous set of experiments, where, in gen-
eral, TGF-b1 was able to reverse much of the IL-1b-induced
change in phenotype, but BMP-2 did not (data not shown).
However, FGF-18 (200 ng/ml) showed a novel pattern.
FGF-18 increased ADAMTS-4, COL2A1, aggrecan and
BMP-2, but also increased IL-8/CXCL8, IL-6, IL-1b, CCL3,
CCL4, CCL20, CXCL3, CXCL6 and CXCL1 expression
(Fig. 6). Increasing the concentration to 400 ng/ml of FGF-
18 did not demonstrate any additional effect (data not
shown). ADAMTS-5 and MMP-13 expression were reduced
slightly by FGF-18 as well as CCL2 and CCL8.EFFECTS OF IL-1b ON CARTILAGEAlthough cell culture experiments can provide valuable
information on the potential for cells to respond in a particu-
lar manner, the isolation of chondrocytes from the matrix, as
NFKBIA
BMP-2
COL2A1
MMP-13
AGGRECAN
ADAMTS-5
NOS2B
CCL20
CCL2
CX3CL1
CXCL6
CXCL1
IL-8
IL-6
IL-1ß
GAPDH
C IL-1ß
Fig. 1. RT-PCR validation of microarray. Chondrocytes from normal
human knee cartilage were treated with 10 ng/ml of IL-1b for 24 h.
RNA extracted from these cells was used for microarray analysis as
well for RT-PCR validation. Control cells (C) received vehicle only.
Total RNA samples from treated and untreated cells were analyzed
by RT-PCR with the primers indicated in Table I. GAPDH was used
as reference for gel loading. Quantiﬁcation of individual bands was
done by NIH IMAGE J software analysis with PCR in the linear
range of product (Table II).
1564 L. J. Sandell et al.: Adult chondrocyte response to IL-1bwell as the stimulation of cells by culture conditions may not
reﬂect the response of cells when they are resident in the
extensive ECM of cartilage. In order to test whether these
cell culture experiments simulate in vivo effects, IL-1b was
cultured with freshly isolated cartilage explants (Fig. 7).
RNA was isolated directly from the cartilage without prior
isolation of cells. Genes representing the different classes
of changes in gene expression were tested and all demon-
strated the same results as the cell culture experiments. For
example, ADAMTS-5, COL2A1 and aggrecan were
reduced; ADAMTS-4, MMP-13, BMP-2, TNF-a, NFKBIA,
IL-8, IL-6, IL-1b, CCL3L1, CCL2, CX3CL1 and CXCL1
were increased.COMPUTATIONAL ANALYSIS TO PREDICT
REGULATORY DOMAINSGenes that are transcriptionally co-expressedmay contain
common regulatory motifs in their DNA ﬂanking domains. To
begin to analyze the regulatorymechanism of the chemokine
genes, the up-regulated chemokines (Table II) were subdi-
vided into two categories: Group 1 mRNAs were increased
25e75-fold when exposed to 10 ng/ml IL-1b and consisted
of CCL3, CCL4, CCL20, CXCL1, CXCL2, CXCL3, CXCL6,
CXCL8, CCL3L1, and the cytokine IL-6. Group 2 mRNAs
were increased 3e12-fold and consisted of CCL2, CCL5,
CCL8,CXCL5, andCX3CL1. Thepromoters of all chemokinegenes identiﬁed were either analyzed as a single group
(Table III), or those belonging to Group 1 were analyzed sep-
arately (Table IV).Wehavepreviously used thismethodology
to analyze transcription factor bindingmotifs in a group of car-
tilage genes16. The R-score indicates the probability that the
transcription factor corresponding to this motif will bind to the
promoter of these genes; the higher the R-score, the more
likely it is to bind [>ln 10 (ln 10¼ 2.3) is in the top 10%]. Al-
though the bindingmust be veriﬁed experimentally,R-scores
over 2 have been demonstrated to have a high likelihood of
functional signiﬁcance15. Overall, many transcription factor
binding motifs known to be involved in expression of pro-in-
ﬂammatory cytokine-induced genes were identiﬁed: NF-kB,
AML1, MEF-3, IRF-7, C/EBPb, AP-1, ORF and TCF11
20e23. However, when only theGroup 1 geneswere analyzed
the overall R-scores of the transcription factor binding motifs
increased indicating more similarity in gene regulatory
domains (Table IV). The predominant transcription factor
binding motifs identiﬁed in the Group 1 genes were MEF-3,
C/EBPb, IRF-7, Pax-4, AML-1 and those related to NF-kB,
c-Rel, and p65.
The ﬁnal group of IL-1b-induced genes examined for
common transcription factor binding sites was a group
that was highly responsive to IL-1b (increased with only
0.01 ng/ml) and rapidly up-regulated in 1e4 h. These genes
include IL-6, CXCL8/IL-8, CX3CL1, CCL2, CCL8, CCL20,
NOS2B, NFKBIA, TNF-a, and BMP-2. Interestingly, the
analysis suggests that in these genes, the highly repre-
sented transcription factor binding sites are almost solely
related to NF-kB (Table V).Discussion
The large scale screening procedure where 34,580
probes representing 24,650 genes and 37,123 gene tran-
scripts are analyzed at once provided an overall view of
the primary response of normal adult articular chondrocytes
to IL-1b. We show that one of the predominant responses of
human adult articular chondrocytes to exposure to IL-1b is
a dramatic increase in a large set of chemokines and other
genes related to the inﬂammatory cascade. Chemokines
are produced in inﬂamed synovial tissue by the synovium,
macrophages and ﬁbroblast-like synoviocytes24e26 and
are thought to be key regulators of the inﬂammatory pro-
cess27 where they function in the recruitment of neutrophils,
monocytes, immature dendritic cells, B cells and activated T
cells28. Therefore, the production of a large array of chemo-
kines and other pro-inﬂammatory molecules under the inﬂu-
ence of IL-1b could signiﬁcantly alter the metabolism of
chondrocytes in addition to the well-accepted increase in
certain degradative enzymes. Furthermore, speciﬁc chemo-
kines, CXCL8/IL-8 and CXCL1 have been shown to alter
the chondrocyte phenotype by inducing hypertrophic
differentiation29.
The most highly up-regulated genes by IL-1b, E-selectin
(endothelial leukocyte adhesion molecule, SELE), LIF and
CSF-3 have been shown to be regulated by IL-1b in other tis-
sues. CSF has not been previously demonstrated in chondro-
cytes induced by IL-1b, but has been identiﬁed in synovial
cells in rheumatoid arthritis30,31 and shown to exacerbate
collagen-induced arthritis in mice32. E-selectin is an adhesion
molecule that is thought to be responsible for the accumula-
tion of blood leukocytes at sites of inﬂammation by mediating
the adhesion of cells to the vascular lining. To our knowledge,
E-selectin has not been identiﬁed in cartilage, but is known to
beup-regulatedby IL-1b inendothelial cells33. Theexpression
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Fig. 2. Dose response of chemokines and matrix molecules to IL-1b. (A) Chondrocytes from normal human knee cartilage were treated with
0.01, 0.1 and 1 ng/ml of IL-1b for 24 h. Control cells (C) received vehicle only. RT-PCR was done with indicated primers and GAPDH was used
as reference. (B) Quantitation of RT-PCR analysis with gene expression normalized to GAPDH expression using NIH IMAGE J software. Pixel
intensity is given in arbitrary units (AU).
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0, 1, 4, 8, 12, and 24 h. Control cells (C) received vehicle only.
RT-PCR was done with indicated primers with GAPDH used as
reference.
1566 L. J. Sandell et al.: Adult chondrocyte response to IL-1bof SELEwas not further analyzed in these studies, but it could
be an important player in the pathogenesis of OA due to the
ability to recruit and retain additional inﬂammatory players.
LIF has been demonstrated in cartilage from OA patients
and up-regulated by IL-1b25,34e36.
In this study, we further analyzed the increased produc-
tion of the chemokines CCL2, CCL3, CCL4, CCL5, CCL8,
CCL20, CCL3L1, CX3CL1, CXCL1, CXCL2, CXCL3,
CXCL5, CXCL6, and CXCL8 (IL-8). Their expression at dif-
ferent concentrations of IL-1b and over a 24 h time course
demonstrated that there are speciﬁc subsets of genes that
are co-regulated. The expression of these genes was com-
pared with the expression of the proteases ADAMTS-4,
ADAMTS-5, MMP-13; the matrix genes COL2A1 and
aggrecan; the growth and differentiation factor BMP-2; the
cytokines IL-1b, IL-6 and TNF-a; the nitric oxide producing
enzyme NOS2B; and the NF-kB inhibitor NFKBIA.
Interestingly, the chemokine SDF-1 (CXCL12), a chemo-
kine associated with chemoattraction of stem cells, was
not detected in cartilage stimulated by IL-1b. This result is
not unexpected as SDF-1 is considered a homeostatic reg-
ulator of tissue remodeling rather than an inﬂammatory
mediator. SDF-1 is normally expressed by stromal cells of
numerous tissues and actually down-regulated by IL-1b
and TNF-a in dermal wound healing37, thus providing addi-
tional support for the validity of the chondrocyte response.The production of a limited group of chemokines has been
reported in cartilage9,20,38. Loeser and colleagues reported
that NF-kB mediates the stimulation of cytokine and chemo-
kine expression in response to ﬁbronectin fragments. In
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Fig. 5. Reversal of IL-1b-induced phenotype by TGF-b1. Chondrocytes from normal knee cartilage and preserved areas of OA knee cartilage
were exposed to 0.1 ng/ml of IL-1b for 24 h. Control cells (C) received vehicle alone. After 24 h, medium containing IL-1b was removed and
fresh medium containing 10 ng/ml of TGF-b1 was added for 48 h. RNA samples were analyzed by RT-PCR with indicated primers. GAPDH
was used as reference for gel loading. Lanes denoted as (IL-1b) indicate that cells were treated with IL-1b for 24 h and were not treated with
TGF-b1; lanes denoted as TGF-b1 (IL-1b) indicate cells received TGF-b1 after removal of IL-1b; ^ indicates that the bands were too low to
quantify; w indicates no change.
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GRO-a (CXCL1), GRO-b (CXCL2), GRO-g (CXCL3), MCP-1
(CCL2), IL-8 (CXCL8) and the cytokine IL-6 and showed
that IL-1b could mimic the effect of the ﬁbronectin frag-
ments38. These authors reported low levels of chemokines
in the cells from OA patients and moderate increases with
IL-1b (2e5-fold). This study differs from ours in that all of their
chondrocytes were isolated from cartilage from OA patients
while amajority of our studies were done on normal chondro-
cytes. This is an important difference because we ﬁnd that
normal chondrocytes have very low levels of chemokines
and we observed a trend to an increase in our compliment
of chemokines when tissue from OA patients was used. In
fact, in our experiments, when tissues from patients with
OA are probed for this set of chemokines, the result resem-
bles the chemokine pattern established here for IL-1b induc-
tion and may reﬂect the exposure of the OA cartilage to the
cytokine.
We consistently observed an increase in the chemokine
CCL5/RANTES with 0.1 ng/ml of IL-1b beginning at 4 h
and continuing through 24 h. It is present in chondrocytes
from OA tissue, but not in normal chondrocytes. CCL5/
RANTES has been associated with rheumatoid arthritis
where it is synthesized by synovial ﬁbroblasts, T cells and
mononuclear cells in synovial ﬂuid, and is thought to serveas a chemoattractant for T cells and monocytes. In fact,
inhibition of CCL5/RANTES by Met-RANTES, which blocks
the receptors CCR-1 and CCR-5, caused amelioration of
adjuvant-induced arthritis in rats39. CCL5 has previously
been shown to be made by chondrocytes20.
ADAMTS-4 and ADAMTS-5 are the two enzymes that
have been isolated from articular cartilage and identiﬁed
as aggrecanase-1 and -2, respectively. In our studies,
ADAMTS-4 is present at very low levels in cartilage from
both normal and OA patients, however, it is induced with
IL-1b, consistent with published studies40,41. We investi-
gated this induction in more detail and found that
ADAMTS-4 can be detected with exposure to as little as
0.01 ng/ml of IL-1b. When compared to MMP-13 gene
expression, the concentration dependent rate of increase
was greater, and the time course of increase was different:
ADAMTS-4 increased by 4 h and decreased by 24 h,
whereas MMP-13 increased at 8 h and remained high at
24 h. Clearly, these two enzymes are regulated through
independent signal transduction pathways.
For ADAMTS-5, our studies clearly demonstrate high
expression in both chondrocyte cell and cartilage explant
cultures of human cartilage, again consistent with previous
ﬁndings41,42. Whereas previous studies showed no effect of
IL-1b on the expression of ADAMTS-5, we showed that
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Fig. 6. Effect of FGF-18 on IL-1b-induced phenotype. Chondrocytes
from preserved areas of OA knee cartilage were treated with
0.01 ng/ml of IL-1b for 24 h. At 24 h, 200 ng/ml of FGF-18 was
added and cultured for another 24 h. Control cells (C) received ve-
hicle alone. RNA samples were analyzed by RT-PCR with indicated
primers. GAPDH was used as reference for gel loading.
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Fig. 7. Effect of IL-1b on cartilage explants in culture. Cartilage ex-
plants from the preserved areas of knees of OA patients were
treated with 10 ng/ml of IL-1b for 24 h. Control tissue (C) received
vehicle alone. RNA samples were analyzed by RT-PCR with indi-
cated primers. GAPDH was used as reference for gel loading.
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expression level of ADAMTS-5 in cultured chondrocytes
and in explant tissue. However, it is becoming apparent
that ADAMTS-5 is highly expressed in normal articular43,44
and growth plate cartilage tissues45 in which it is thought to
participate in normal proteoglycan turnover. In the study by
Aigner and colleagues41, ADAMTS-5 mRNA levels were
higher when cells were cultured with serum. In our studies,
serum is used in cell cultures, and our time course
experiments indicate that over 24 h, ADAMTS-5 mRNA
increases; this increase is either susceptible to down-
regulation by IL-1b or IL-1b inhibits the serum-induced
increase (see Fig. 3).
To explore potential transcriptional regulation of the che-
mokines, they were sub-classiﬁed into two sets based on
the extent of up-regulation and subjected to a computational
analysis for transcription factor binding sites that are highly
represented in each set15,16. For each group, a distinct set
of transcription factor binding sites were found, many of
which have previously been experimentally veriﬁed. Actual
binding probability would depend on a variety of other
factors, including the cooperative binding of transcription
factors and the concentration of the transcription factorswithin the nucleus. Chang et al.15 have demonstrated that
the computed scores are highly correlated with binding
probability, such that promoters with higher combined
scores were more likely to be bound by the transcription
factor than promoters with lower scores. In the genes
most highly up-regulated, binding sites to factors related
to NF-kB and IRF were highly represented. Both these tran-
scription factor families have been documented to up-
regulate RANTES (CCL5) transcription (12-fold increase)
on their own38,46,47, and in a concerted manner21. NF-kB
has been shown to regulate a speciﬁc subset of chemo-
kines38; however, Amos and colleagues recently demon-
strated that inhibition of NF-kB activity did not inhibit all
inﬂammatory mediators48, therefore, there are likely other
transcriptional mechanisms involved. Here, we identiﬁed
two additional potential transcription factors for this set of
genes: MEF-3 and C/EBPb; in fact, binding sites for these
two transcription factors were the most highly represented
in this set of highly expressed chemokine genes induced
by IL-1b. C/EBPb has been previously associated with IL-
1b-induced changes in chondrocyte gene expression. C/
EBPb is increased in chondrocytes by IL-1b and down-reg-
ulates the cartilage matrix genes COL2A1 and MIA/CD-
RAP23,49; in addition, we have shown that C/EBPb plays
an important role in repressing cartilage gene expression
in non-cartilaginous tissues50. Neither MEF-3 nor C/EBPb
has been shown to regulate chemokine genes, but future
experiments will be designed to test their role.
This computational method was also applied to the group
of co-expressed genes that are very sensitive to low doses
of IL-1b and are expressed at early time points. This group
Table III
Transcription factor binding motif prevalence in genes of Groups 1
and 2
TRANSFAC motif
accession number
Transcription
factor
R-Score
M00774 NF-kB 2.1467
M00751 AML1 2.0688
M00271 AML-1a 2.0656
Generalized motif (Gary
Stormo, personal communication)
NF-kB 2.0468
M00319 MEF-3 1.906
M00453 IRF-7 1.8815
M00109 C/EBPb 1.8484
M00517 AP-1 1.8354
M00772 ORF 1.7779
M0089 TCF11-Maf 1.7505
Table V
Transcription factor binding motif prevalence in genes induced by
low IL-1b/1e4 h
TRANSFAC motif
accession number
Transcription factor R-Score
M00774 NF-kB 3.40
M00208 NF-kB 3.01
MA0061 NF-kB 2.88
M00054 NF-kB 2.82
Generalized motif
(Gary Stormo, personal
communication)
NF-kB 2.60
M00052 NF-kB 2.57
MA0107 p65 2.54
M00261 Olf-1 2.43
M00053 c-REL 2.42
M00194 NF-kB 2.39
MA0101 c-REL 2.36
M00977 EBF 2.26
1569Osteoarthritis and Cartilage Vol. 16, No. 12of genes was predicted to be predominantly regulated by
proteins that bind at NF-kB binding sites on the gene. How-
ever, two other related factors, Olf-1 and early B-cell factor
(EBF) scored greater than 2.0. These two proteins are
closely related members of the helix-loop-helix transcription
factor family and have been shown to function in olfactory
gene regulation, neuronal differentiation51, B cell develop-
ment52, adipogenesis53 and are expressed in the connec-
tive tissues surrounding chondrogenic condensations and
developing tendons54.
The chemokine receptors CCR-1, CCR-2, CCR-3, CCR-
5, CXCR-1 and CXCR-2 are present in cartilage and up-
regulated by IL-1b28,29. The presence of receptors, as well
as production of chemokines, strongly suggests that
chemokines may regulate cellular responses that are indi-
rectly or directly related to inﬂammation and immune
responses. These studies also showed that release of the
collagenase, MMP-3, was markedly enhanced by stimula-
tion with chemokines, particularly MCP-1, RANTES and
GRO-a, and that this response was receptor mediated28.
In light of the previous ﬁnding of the presence of a full
complement of receptors, it is reasonable to predict that
chondrocytes will be able to respond to the chemokines
up-regulated by IL-1b.
Reversal of certain aspects of the IL-1b-induced pheno-
type has been evaluated for TGF-b155.We compared the po-
tential to reverse this newly identiﬁed phenotype by TGF-b1,
BMP-2 and FGF-18. TGF-b1 was best able to reverse the
phenotype having effects on reversal of the down-regulationTable IV
Transcription factor binding motif prevalence in Group 1 chemokine
genes
TRANSFAC motif
accession number
Transcription factor R-Score
M00319 MEF-3 3.59
M00109 C/EBPb 3.1041
M0074 NF-kB 2.6676
Generalized motif
(Gary Stormo, personal
communication)
NF-kB 2.6286
M00453 IRF-7 2.426
M0068 Pax-4 2.316
M0053 c-Rel 2.154
MA0107 P65 2.148
M00052 NF-kB 2.145
M00751 AML1 2.130ofmatrixmolecules, and reversal of someof theup-regulation
of chemokines. TGF-b1, however, had opposite effects on
two of the enzymes considered important for matrix degrada-
tion: it lowered the IL-1b-induced increase in MMP-13, but
increased the expression of ADAMTS-4. These observations
conﬁrm data presented by Hasty and colleagues56 who dem-
onstrated that TGF-b could decreaseMMP-13andMoulharat
and colleagues57 who have shown that TGF-b1 increases
both mRNA levels of ADAMTS-4 and cleavage products of
aggrecan. Potential reversal by BMP-2 proved to be
disappointing as BMP-2 did not affect matrix, enzyme or
chemokine synthesis: higher concentration did not increase
the effect (up to 200 ng/ml). Without IL-1b, control experi-
ments showed that BMP-2 could increase COL2A1 gene
expression (data not shown).
In summary, we have shown a large set of genes that are
up-regulated by the cytokine IL-1b in adult normal cartilage
and from patients with OA. Genes from both types of carti-
lage are affected similarly by IL-1b. By computational anal-
ysis, two new transcription factors are now associated with
this set of up-regulated genes, MEF-3 and C/EBP; however,
the early response of genes to IL-1b is most likely due to the
NF-kB pathway. Reversal of the IL-1b-induced phenotype is
not accomplished by BMP-2, although it is expressed in the
tissue. TGF-b1 can partially reverse the phenotype, while
FGF-18 can reverse certain aspects and augment others.
Given the results from rheumatoid arthritis and other inﬂam-
matory diseases, it can be expected that this exuberant
increase in a wide range of chemokines will have a signiﬁ-
cant impact on the cells of cartilage and should be consid-
ered in the pathophysiology of OA. The chemokine proﬁle
from OA patient tissue may reﬂect the cytokine history of
the tissue, therefore, we are proﬁling a large sample of
patient and normal tissue to determine whether there is
a ‘‘IL-1b footprint’’ for OA.Conﬂict of interest
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